Drug Discovery News,in collaboration with investment bank Mizuho Securities USA Inc., is conductinga survey on the state of funding and views on companion diagnostics, oncologyand pharma. The goal of this survey is to gain a better understanding ofcurrent and future trends in R&D activity.
Our web-based survey takes about four to five minutes tocomplete.
All information will remain confidential, and onlyaggregate, not individual responses nor company names, will be published. Ifyou are interested in receiving a copy of the survey results, please indicatethat at the end of the survey.
In providing a response to this survey, you represent thatyou have not knowingly disclosed (i) any material non-public information; (ii)any trade secret or other proprietary information; (iii) information which youhave a duty or agreement to keep confidential; or (iv) information obtainedfrom any person expecting such information to be kept confidential or which youbelieve to be confidential.